Headlines
Bloomberg MarketsWhat to Expect From Trump's Speech on IranBloomberg MarketsGold Traders Made a Record $3.9 Billion in 2025, Coalition SaysFinancial TimesTrump threatened to stop weapons for Ukraine unless Europe joined Hormuz coalitionBloomberg MarketsAccor Agrees to Sell Hotel Stake to Blackstone ConsortiumFinancial TimesSpaceX filing kicks off largest IPO process in historyBloomberg MarketsBank of Canada Agreed Iran War Shouldn’t Overtake Other RisksBloomberg MarketsHasbro Pulls Some Systems Offline as Breach Inquiry ContinuesBloomberg MarketsOil Price Surge Not Slowing M&A, Morgan Stanley's Miles SaysBloomberg MarketsMamdani Spars With NYC City Council Over $127 Billion BudgetBloomberg MarketsSuper Micro Co-Founder Pleads Not Guilty in China Smuggling CaseFinancial TimesEli Lilly wins US approval for weight-loss drug in pill formFinancial TimesUS Supreme Court signals doubts over Trump’s birthright citizenship challengeBloomberg MarketsBain’s Gross Says CEOs Get AI Wrong, Focus on Tech Over StrategyBloomberg MarketsAfter Decade of Slumps, Argentine Peso Becomes Surprise ‘Haven’Bloomberg MarketsNigerian Banks Raise $3.4 Billion to Meet New Capital StandardsBloomberg MarketsWhat to Expect From Trump's Speech on IranBloomberg MarketsGold Traders Made a Record $3.9 Billion in 2025, Coalition SaysFinancial TimesTrump threatened to stop weapons for Ukraine unless Europe joined Hormuz coalitionBloomberg MarketsAccor Agrees to Sell Hotel Stake to Blackstone ConsortiumFinancial TimesSpaceX filing kicks off largest IPO process in historyBloomberg MarketsBank of Canada Agreed Iran War Shouldn’t Overtake Other RisksBloomberg MarketsHasbro Pulls Some Systems Offline as Breach Inquiry ContinuesBloomberg MarketsOil Price Surge Not Slowing M&A, Morgan Stanley's Miles SaysBloomberg MarketsMamdani Spars With NYC City Council Over $127 Billion BudgetBloomberg MarketsSuper Micro Co-Founder Pleads Not Guilty in China Smuggling CaseFinancial TimesEli Lilly wins US approval for weight-loss drug in pill formFinancial TimesUS Supreme Court signals doubts over Trump’s birthright citizenship challengeBloomberg MarketsBain’s Gross Says CEOs Get AI Wrong, Focus on Tech Over StrategyBloomberg MarketsAfter Decade of Slumps, Argentine Peso Becomes Surprise ‘Haven’Bloomberg MarketsNigerian Banks Raise $3.4 Billion to Meet New Capital Standards
Home/MarketWatch Top Stories
Back
MARKETS:
SPY+0.26%
DIA+0.23%
QQQ-0.14%
IWM+0.29%
GLD-0.40%
USO+1.64%
MarketWatch Top Storiesmarkets

America has a new weight-loss drug, and it’s a pill

MarketWatch Top Stories
Wednesday, April 1, 2026 at 4:32 PM
~4 min read

Original Report

Lilly’s new GLP-1 medication, which is called Foundayo, can be taken once daily at any time. It will compete against the Wegovy pill.

Glass House Analysis

This story reflects the interconnected nature of modern economic systems, where developments in one sector inevitably affect others. Understanding these connections is essential for grasping how policy decisions and market movements translate into real-world outcomes for families, workers, and communities. The economy is not an abstract system of numbers—it's the sum total of decisions about who works, who prospers, and who struggles.

The implications extend beyond the immediate news cycle. Every economic development creates ripples that affect employment, prices, and opportunities in ways that may not be immediately visible but are deeply felt. By tracking these connections, we can better understand how the economy truly works—not as an abstract machine, but as a human system shaped by and shaping the lives of millions.

Enjoyed this analysis?

Get the Glass House Briefing every morning—market news that actually makes sense, delivered free to your inbox.

No spam. Unsubscribe anytime.

More Stories

Economic Context

S&P 500
+0.26%
Dow Jones
+0.23%
NASDAQ 100
-0.14%
Russell 2000
+0.29%